The DOI matches its Crossref record; 179 of the 179 references it cites were found in a registry or an index.
Role of miRNA-Regulated Cancer Stem Cells in the Pathogenesis of Human Malignancies
Open accessAbstract
Recent biomedical discoveries have revolutionized the concept and understanding of carcinogenesis, a complex and multistep phenomenon which involves accretion of genetic, epigenetic, biochemical, and histological changes, with special reference to MicroRNAs (miRNAs) and cancer stem cells (CSCs). miRNAs are small noncoding molecules known to regulate expression of more than 60% of the human genes, and their aberrant expression has been associated with the pathogenesis of human cancers and the regulation of stemness features of CSCs. CSCs are the small population of cells present in human malignancies well-known for cancer resistance, relapse, tumorigenesis, and poor clinical outcome which compels the development of novel and effective therapeutic protocols for better clinical outcome. Interestingly, the role of miRNAs in maintaining and regulating the functioning of CSCs through targeting various oncogenic signaling pathways, such as Notch, wingless (WNT)/β-Catenin, janus kinases/ signal transducer and activator of transcription (JAK/STAT), phosphatidylinositol 3-kinase/ protein kinase B (PI3/AKT), and nuclear factor kappa-light-chain-enhancer of activated B (NF-kB), is critical and poses a huge challenge to cancer treatment. Based on recent findings, here, we have documented the regulatory action or the underlying mechanisms of how miRNAs affect the signaling pathways attributed to stemness features of CSCs, such as self-renewal, differentiation, epithelial to mesenchymal transition (EMT), metastasis, resistance and recurrence etc., associated with the pathogenesis of various types of human malignancies including colorectal cancer, lung cancer, breast cancer, head and neck cancer, prostate cancer, liver cancer, etc. We also shed light on the fact that the targeted attenuation of deregulated functioning of miRNA related to stemness in human carcinogenesis could be a viable approach for cancer treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/β-catenin pathway
Zhou, W., Li, Y., Gou, S., Xiong, J., Wu, H., Wang, C., Yan, H., & Liu, T. (2015) · Oncotarget · doi:10.18632/oncotarget.5317 · Cited by 74
RetractedMicroRNA 628 suppresses migration and invasion of breast cancer stem cells through targeting SOS1
Lin, C.-H., Gao, B., Yan, X., Lei, Z., Chen, K., Li, Y., Zeng, Q., Chen, Z., & Li, H. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s164575 · Cited by 36
RetractedmiR-206 inhibits cancer initiating cells by targeting EHF in gastric cancer
Gong, Y.-C., Ren, G., Liu, B., et al. (2017) · Oncology Reports · doi:10.3892/or.2017.5794 · Cited by 6
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
NF-κB signaling in inflammation
Liu, T., Zhang, L., Joo, D., & Sun, S.-C. (2017) · Signal Transduction and Targeted Therapy · doi:10.1038/sigtrans.2017.23 · Cited by 8,791
MicroRNA signatures in human cancers
Calin, G. A., & Croce, C. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1997 · Cited by 7,590
MicroRNAs: small RNAs with a big role in gene regulation
He, L., & Hannon, G. J. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1379 · Cited by 7,118
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
Nusse, R., & Clevers, H. (2017) · Cell · doi:10.1016/j.cell.2017.05.016 · Cited by 4,342
The impact of microRNAs on protein output
Baek, D., Villén, J., Shin, C., Camargo, F. D., Gygi, S. P., & Bartel, D. P. (2008) · Nature · doi:10.1038/nature07242 · Cited by 3,592
Ovarian cancer statistics, 2018
Torre, L. A., Trabert, B., DeSantis, C. E., Miller, K. D., Samimi, G., Runowicz, C. D., Gaudet, M. M., Jemal, A., & Siegel, R. L. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21456 · Cited by 3,492
The Versatile Role of microRNA-30a in Human Cancer
Wang, C., Yang, X., Chen, Y., & Chen, L. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000471111 · Cited by 3,409
Lung cancer: current therapies and new targeted treatments
Hirsch, F. R., Scagliotti, G. V., Mulshine, J. L., Kwon, R., Curran, W. J., Wu, Y.-L., & Paz-Ares, L. (2017) · The Lancet · doi:10.1016/s0140-6736(16)30958-8 · Cited by 3,283
Batlle, E., & Clevers, H. (2017) · Nature Medicine · doi:10.1038/nm.4409 · Cited by 2,769
Bushati, N., & Cohen, S. M. (2007) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.23.090506.123406 · Cited by 2,750
Colorectal cancer statistics, 2014
Siegel, R., DeSantis, C., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21220 · Cited by 2,562
Regulation of microRNA function in animals
Gebert, L. F. R., & MacRae, I. J. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0045-7 · Cited by 2,284
MicroRNAs in cancer: biomarkers, functions and therapy
Hayes, J., Peruzzi, P. P., & Lawler, S. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.06.005 · Cited by 2,049
MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review
Iorio, M. V., & Croce, C. M. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201100209 · Cited by 1,739
The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs
Wellner, U., Schubert, J., Burk, U. C., Schmalhofer, O., Zhu, F., Sonntag, A., Waldvogel, B., Vannier, C., Darling, D., Hausen, A. Z., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1998 · Cited by 1,699
Dicer is essential for mouse development
Bernstein, E., Kim, S. Y., Carmell, M. A., Murchison, E. P., Alcorn, H., Li, M. Z., Mills, A. A., Elledge, S. J., Anderson, K. V., & Hannon, G. J. (2003) · Nature Genetics · doi:10.1038/ng1253 · Cited by 1,627
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
Liu, C., Kelnar, K., Liu, B., Chen, X., Calhoun-Davis, T., Li, H., Patrawala, L., Yan, H., Jeter, C., Honorio, S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2284 · Cited by 1,400
Kanellopoulou, C., Muljo, S. A., Kung, A. L., Ganesan, S., Drapkin, R., Jenuwein, T., Livingston, D. M., & Rajewsky, K. (2005) · Genes & Development · doi:10.1101/gad.1248505 · Cited by 1,254
NF-κB, an Active Player in Human Cancers
Xia, Y., Shen, S., & Verma, I. M. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0112 · Cited by 1,213
Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors
Krishnamurthy, N., & Kurzrock, R. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2017.11.002 · Cited by 1,026
DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal
Wang, Y., Medvid, R., Melton, C., Jaenisch, R., & Blelloch, R. (2007) · Nature Genetics · doi:10.1038/ng1969 · Cited by 1,025
Cancer Stem Cells: Basic Concepts and Therapeutic Implications
Nassar, D., & Blanpain, C. (2016) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044438 · Cited by 869
The Notch target genes Hey1 and Hey2 are required for embryonic vascular development
Fischer, A., Schumacher, N., Maier, M., Sendtner, M., & Gessler, M. (2004) · Genes & Development · doi:10.1101/gad.291004 · Cited by 655
Yu, Z., Pestell, T. G., Lisanti, M. P., & Pestell, R. G. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.08.022 · Cited by 647
Reddy, K. B. (2015) · Cancer Cell International · doi:10.1186/s12935-015-0185-1 · Cited by 613
Taitt, H. E. (2018) · American Journal of Men's Health · doi:10.1177/1557988318798279 · Cited by 463
Familial gastric cancer: genetic susceptibility, pathology, and implications for management
Oliveira, C., Pinheiro, H., Figueiredo, J., Seruca, R., & Carneiro, F. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71016-2 · Cited by 427
Interplay between miRNAs and human diseases
Paul, P., Chakraborty, A., Sarkar, D., Langthasa, M., Rahman, M., Bari, M., Singha, R. S., Malakar, A. K., & Chakraborty, S. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.25854 · Cited by 420
Cancer stem cells, cancer cell plasticity and radiation therapy
Vlashi, E., & Pajonk, F. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.07.001 · Cited by 327
Cancer stem cell signaling pathways
Matsui, W. H. (2016) · Medicine · doi:10.1097/md.0000000000004765 · Cited by 320
Noncanonical NF-κB Signaling in Health and Disease
Cildir, G., Low, K. C., & Tergaonkar, V. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.03.002 · Cited by 301
Smahi, A. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.20.2371 · Cited by 300
Papaccio, F., Paino, F., Regad, T., Papaccio, G., Desiderio, V., & Tirino, V. (2017) · Stem Cells Translational Medicine · doi:10.1002/sctm.17-0138 · Cited by 292
Targeting Notch signalling pathway of cancer stem cells
Venkatesh, V., Nataraj, R., Thangaraj, G. S., Karthikeyan, M., Gnanasekaran, A., Kaginelli, S. B., Kuppanna, G., Kallappa, C. G., & Basalingappa, K. M. (2018) · Stem Cell Investigation · doi:10.21037/sci.2018.02.02 · Cited by 275
Hedgehog Signaling in the Maintenance of Cancer Stem Cells
Cochrane, C., Szczepny, A., Watkins, D., & Cain, J. (2015) · Cancers · doi:10.3390/cancers7030851 · Cited by 271
STAT3, stem cells, cancer stem cells and p63
Galoczova, M., Coates, P., & Vojtesek, B. (2018) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-018-0078-0 · Cited by 269
The NF-κB Pathway and Cancer Stem Cells
Rinkenbaugh, A., & Baldwin, A. (2016) · Cells · doi:10.3390/cells5020016 · Cited by 260
Mohammed, M. K., Shao, C., Wang, J., Wei, Q., Wang, X., Collier, Z., Tang, S., Liu, H., Zhang, F., Huang, J., et al. (2016) · Genes & Diseases · doi:10.1016/j.gendis.2015.12.004 · Cited by 259
Yang, K., Wang, X., Zhang, H., Wang, Z., Nan, G., Li, Y., Zhang, F., Mohammed, M. K., Haydon, R. C., Luu, H. H., et al. (2016) · Laboratory Investigation · doi:10.1038/labinvest.2015.144 · Cited by 241
Bourguignon, L. Y. W., Earle, C., Wong, G., Spevak, C. C., & Krueger, K. (2012) · Oncogene · doi:10.1038/onc.2011.222 · Cited by 239
Liu, C., Liu, R., Zhang, D., Deng, Q., Liu, B., Chao, H.-P., Rycaj, K., Takata, Y., Lin, K., Lu, Y., et al. (2017) · Nature Communications · doi:10.1038/ncomms14270 · Cited by 228
Cancer stem cells: A brief review of the current status
Kuşoğlu, A., & Biray Avcı, Ç. (2019) · Gene · doi:10.1016/j.gene.2018.09.052 · Cited by 221
Hsieh, I.-S., Chang, K.-C., Tsai, Y.-T., Ke, J.-Y., Lu, P.-J., Lee, K.-H., Yeh, S.-D., Hong, T.-M., & Chen, Y.-L. (2013) · Carcinogenesis · doi:10.1093/carcin/bgs371 · Cited by 219
Zhang, W. C., Chin, T. M., Yang, H., Nga, M. E., Lunny, D. P., Lim, E. K. H., Sun, L. L., Pang, Y. H., Leow, Y. N., Malusay, S. R. Y., et al. (2016) · Nature Communications · doi:10.1038/ncomms11702 · Cited by 202
Targeting self-renewal pathways in cancer stem cells: clinical implications for cancer therapy
Borah, A., Raveendran, S., Rochani, A., Maekawa, T., & Kumar, D. S. (2015) · Oncogenesis · doi:10.1038/oncsis.2015.35 · Cited by 192
Octamer 4/microRNA‐1246 signaling axis drives Wnt/β‐catenin activation in liver cancer stem cells
Chai, S., Ng, K., Tong, M., Lau, E. Y., Lee, T. K., Chan, K. W., Yuan, Y., Cheung, T., Cheung, S., Wang, X., et al. (2016) · Hepatology · doi:10.1002/hep.28821 · Cited by 188
Lv, C., Li, F., Li, X., Tian, Y., Zhang, Y., Sheng, X., Song, Y., Meng, Q., Yuan, S., Luan, L., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01059-5 · Cited by 183
Fernandez-Valdivia, R., Takeuchi, H., Samarghandi, A., Lopez, M., Leonardi, J., Haltiwanger, R. S., & Jafar-Nejad, H. (2011) · Development · doi:10.1242/dev.060020 · Cited by 175
Ren, D., Lin, B., Zhang, X., Peng, Y., Ye, Z., Ma, Y., Liang, Y., Cao, L., Li, X., Li, R., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17971 · Cited by 172
Emerging roles of microRNAs in cancer
Vannini, I., Fanini, F., & Fabbri, M. (2018) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2018.01.001 · Cited by 164
microRNAs: important regulators of stem cells
Li, N., Long, B., Han, W., Yuan, S., & Wang, K. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0551-0 · Cited by 163
Xiao, W. L., Gao, Z., Duan, Y., Yuan, W., & Yang, K. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0507-3 · Cited by 162
Hu, J., Cheng, Y., Li, Y., Jin, Z., Pan, Y., Liu, G., Fu, S., Zhang, Y., Feng, K., & Feng, Y. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.06.005 · Cited by 160
Chen, M.-W., Yang, S.-T., Chien, M., Hua, K., Wu, C., Hsiao, S. M., Lin, H., Hsiao, M., Su, J.-L., & Wei, L. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-1115 · Cited by 156
Targeting Signaling Pathways in Cancer Stem Cells for Cancer Treatment
Koury, J., Zhong, L., & Hao, J. (2017) · Stem Cells International · doi:10.1155/2017/2925869 · Cited by 155
Yang, Y., Ding, L., Hu, Q., Xia, J., Sun, J., Wang, X., Xiong, H., Gurbani, D., Li, L., Liu, Y., et al. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0710-z · Cited by 150
Xu, Y., Huang, J., Ma, L., Shan, J., Shen, J., Yang, Z., Liu, L., Luo, Y., Yao, C., & Qian, C. (2016) · Cancer Letters · doi:10.1016/j.canlet.2015.11.034 · Cited by 148
Laursen, L. (2014) · Nature · doi:10.1038/516s2a · Cited by 144
Head and Neck Cancer Stem Cells
Krishnamurthy, S., & Nor, J. E. (2011) · Journal of Dental Research · doi:10.1177/0022034511423393 · Cited by 144
Liu, T., Chi, H., Chen, J., Chen, C., Huang, Y., Xi, H., Xue, J. F., & Si, Y. (2017) · Gene · doi:10.1016/j.gene.2017.08.008 · Cited by 144
TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression
Ottaviani, S., Stebbing, J., Frampton, A. E., Zagorac, S., Krell, J., de Giorgio, A., Trabulo, S. M. D., Nguyen, V. T. M., Magnani, L., Feng, H., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03962-x · Cited by 139
Lo, W., Yu, C., Chiou, G., Chen, Y., Huang, P., Chien, C., Tseng, L., Chu, P., Lu, K., Chang, K., et al. (2010) · The Journal of Pathology · doi:10.1002/path.2826 · Cited by 137
Gastric cancer stem cells: evidence, potential markers, and clinical implications
Brungs, D., Aghmesheh, M., Vine, K. L., Becker, T. M., Carolan, M., & Ranson, M. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-015-1125-5 · Cited by 136
miR-600 Acts as a Bimodal Switch that Regulates Breast Cancer Stem Cell Fate through WNT Signaling
Helou, R. E., Pinna, G., Cabaud, O., Wicinski, J., Bhajun, R., Guyon, L., Rioualen, C., Finetti, P., Gros, A., Mari, B. P., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.016 · Cited by 136
Yu, C.-C., Tsai, L., Wang, M., Yu, C.-H., Lo, W., Chang, Y.-C., Chiou, G., Chou, M., & Chiou, S. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3840 · Cited by 135
Jeong, J.-Y., Kang, H., Kim, T. H., Kim, G., Heo, J. H., Kwon, A., Kim, S., Jung, S. G., & An, H. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.11.017 · Cited by 126
Leichter, A. L., Sullivan, M. J., Eccles, M. R., & Chatterjee, A. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0584-0 · Cited by 124
Li, B., Lü, Y., Yu, L., Han, X., Wang, H., Mao, J., Shen, J., Tang, J., Tang, J., Li, C., et al. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.08.014 · Cited by 120
The role of microRNAs in the regulation of cancer stem cells
Takahashi, R.-U., Miyazaki, H., & Ochiya, T. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2013.00295 · Cited by 118
MiR-19b/20a/92a regulates the self-renewal and proliferation of gastric cancer stem cells
Wu, Q., Yang, Z., Wang, F., Hu, S., Li, Y., Shi, Y., & Fan, D. (2013) · Journal of Cell Science · doi:10.1242/jcs.127944 · Cited by 117
Tung, S.-L., Huang, W.-C., Hsu, F.-C., Yang, Z.-P., Jang, T.-H., Chang, J.-W., Chuang, C.-M., Lai, C.-R., & Wang, L. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.25 · Cited by 109
Cheng, S., Huang, Y., Lou, C., He, Y., Zhang, Y., & Zhang, Q. (2018) · Cancer Biology & Therapy · doi:10.1080/15384047.2018.1529101 · Cited by 109
Tang, T., Yang, Z., Zhu, Q., Wu, Y., Sun, K., Alahdal, M., Zhang, Y., Xing, Y., Shen, Y., Xia, T., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201801013r · Cited by 105
Fan, X., Chen, X., Deng, W., Zhong, G., Cai, Q., & Lin, T. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-61 · Cited by 104
miR-142-3p attenuates breast cancer stem cell characteristics and decreases radioresistance in vitro
Troschel, F. M., Böhly, N., Borrmann, K., Braun, T., Paping, A., Kiesel, L., Eich, H. T., Götte, M., & Greve, B. (2018) · Tumor Biology · doi:10.1177/1010428318791887 · Cited by 103
Liu, T., Wu, X., Chen, T., Luo, Z., & Hu, X. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1169 · Cited by 100
Wu, Y., Shi, W., Tang, T., Wang, Y., Yin, X., Chen, Y., Zhang, Y., Xing, Y., Shen, Y., Xia, T., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1437-0 · Cited by 100
microRNAs in cancer stem cells: Biology, pathways, and therapeutic opportunities
Asadzadeh, Z., Mansoori, B., Mohammadi, A., Aghajani, M., Haji‐Asgarzadeh, K., Safarzadeh, E., Mokhtarzadeh, A., Duijf, P. H. G., & Baradaran, B. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27885 · Cited by 99
Chang, Y., Zhou, P.-J., Wei, L., Li, W., Ji, Z., Fang, Y., & Gao, W. (2015) · Oncotarget · doi:10.18632/oncotarget.4447 · Cited by 98
Yu, D., Shin, H.-S., Lee, Y. S., & Lee, Y. C. (2014) · Laboratory Investigation · doi:10.1038/labinvest.2014.125 · Cited by 97
Pancreatic Cancer Stem Cells and Therapeutic Approaches
Ercan, G., Karlıtepe, A., & Özpolat, B. (2017) · Anticancer Research · doi:10.21873/anticanres.11628 · Cited by 97
Luo, X., Dong, Z., Chen, Y., Yang, L., & Lai, D. (2013) · Cell Proliferation · doi:10.1111/cpr.12038 · Cited by 96
Cancer Stem Cells in Prostate Cancer: Implications for Targeted Therapy
Leao, R. R. N., Domingos, C., Figueiredo, A., Hamilton, R. J., Tabori, U. Y., & Castelo‐Branco, P. (2017) · Urologia Internationalis · doi:10.1159/000455160 · Cited by 96
Castro, D., Moreira, M., Gouveia, A., Pozza, D. H., & de Mello, R. A. (2017) · Oncotarget · doi:10.18632/oncotarget.20955 · Cited by 95
miRNAs in head and neck cancer revisited
Nagadia, R. H., Pandit, P., Coman, W. B., Cooper-White, J. J., & Punyadeera, C. (2013) · Cellular Oncology · doi:10.1007/s13402-012-0122-4 · Cited by 93
Zhang, L., Guo, X., Zhang, D., Fan, Y., Qin, L., Dong, S., & Zhang, L. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22656 · Cited by 93
Schwarzenbacher, D., Klec, C., Pasculli, B., Cerk, S., Rinner, B., Karbiener, M., Ivan, C., Barbano, R., Ling, H. Y., Wulf-Goldenberg, A., et al. (2019) · Breast Cancer Research · doi:10.1186/s13058-019-1104-5 · Cited by 93
Fan, D., Ren, B., Yang, X., Liu, J., & Zhang, Z. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0432-x · Cited by 92
Jin, Y., Wang, M., Hu, H., Huang, Q., Chen, Y., & Wang, G. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.05.151 · Cited by 91
miR-137 Regulates the Tumorigenicity of Colon Cancer Stem Cells through the Inhibition of DCLK1
Sakaguchi, M., Hisamori, S., Oshima, N., Sato, F., Shimono, Y., & Sakai, Y. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-15-0380 · Cited by 90
Inhibition of miR-328–3p Impairs Cancer Stem Cell Function and Prevents Metastasis in Ovarian Cancer
Srivastava, A. K., Banerjee, A. T., Cui, T., Han, C., Cai, S., Liu, L., Wu, D., Cui, R., Li, Z., Zhang, X., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3668 · Cited by 90
MicroRNA-424 impairs ubiquitination to activate STAT3 and promote prostate tumor progression
Dallavalle, C., Albino, D., Civenni, G., Merulla, J., Ostano, P., Grand, M. M., Rossi, S., Losa, M., D’Ambrosio, G., Sessa, F., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci86505 · Cited by 88
Jiang, C., Long, J., Liu, B., Xu, M. T., Wang, W., Xie, X., Wang, X., & Kuang, M. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0568-3 · Cited by 88
Chakraborty, C., Chin, K., & Das, S. (2016) · Tumor Biology · doi:10.1007/s13277-016-5156-1 · Cited by 85
miR-19 targeting of GSK3β mediates sulforaphane suppression of lung cancer stem cells
Zhu, J., Wang, S., Chen, Y., Li, X., Jiang, Y., Yang, X., Li, Y., Wang, X., Meng, Y., Zhu, M., et al. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.02.020 · Cited by 85
MicroRNA regulation of liver cancer stem cells.
Lou, W., Liu, J., Gao, Y., Zhong, G., Ding, B., Xu, L., & Fan, W. (2018) · Europe PMC (PubMed Central) · Cited by 85
Wang, X., Li, Y., Dai, Y., Liu, Q., Ning, S., Liu, J., Shen, Z., Zhu, D., Jiang, F., Zhang, J., et al. (2016) · Scientific Reports · doi:10.1038/srep36796 · Cited by 84
Bourguignon, L., Earle, C., & Shiina, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091849 · Cited by 84
Wei, Z., Liu, Y., Wang, Y., Zhang, Y., Luo, Q., Man, X., Wei, F., & Yu, X. (2016) · Medical Oncology · doi:10.1007/s12032-016-0842-9 · Cited by 83
Bott, A., Erdem, N., Lerrer, S., Hotz‐Wagenblatt, A., Breunig, C., Abnaof, K., Wörner, A., Wilhelm, H., Münstermann, E., Ben‐Baruch, A., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14915 · Cited by 83
MicroRNA aberrances in head and neck cancer: pathogenetic and clinical significance
Tu, H., Lin, S., & Chang, K. (2013) · Current Opinion in Otolaryngology & Head & Neck Surgery · doi:10.1097/moo.0b013e32835e1d6e · Cited by 81
miR-181b/Notch2 overcome chemoresistance by regulating cancer stem cell-like properties in NSCLC
Wang, X., Meng, Q., Qiao, W., Ma, R., Ju, W., Hu, J., Lu, H., Cui, J., Jin, Z. H., Zhao, Y., et al. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-1072-1 · Cited by 81
Jeong, J.-H., Park, S.-J., Dickinson, S. I., & Luo, J. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.11.034 · Cited by 80
Li, Q., Xie, Y., Wu, Y., Li, L., Liu, Y., Miao, X., Liu, Q., Yao, K., & Xiao, G. (2017) · Oncotarget · doi:10.18632/oncotarget.14512 · Cited by 77
Stem cell division theory of cancer
López‐Lázaro, M. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1062330 · Cited by 76
Moharil, R., Dive, A., Khandekar, S., et al. (2017) · Journal of Oral and Maxillofacial Pathology · doi:10.4103/jomfp.jomfp_132_16 · Cited by 76
Zheng, Z., Liu, J., Yang, Z., Wu, L., Xie, H., Jiang, C., Lin, B.-Y., Chen, T., Xing, C., Liu, Z., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8584 · Cited by 74
Albino, D., Civenni, G., Dallavalle, C., Roos, M. M., Jahns, H., Curti, L., Rossi, S., Pinton, S., D’Ambrosio, G., Sessa, F., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2665 · Cited by 74
MicroRNAs: a new key in lung cancer
Zhang, Y., Yang, Q., & Wang, S. (2014) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-014-2559-9 · Cited by 73
Fu, H., Fu, L., Xie, C. L., Wen-shu, Z., Liu, Y., Zheng, M., & Yu, J. (2017) · Oncology Reports · doi:10.3892/or.2017.5360 · Cited by 73
Guo, Y. X., Cui, J. G., Ji, Z., Cheng, C., Zhang, K., Zhang, C., Chu, M., Zhao, Q., Yu, Z., Zhang, Y., et al. (2017) · Oncogene · doi:10.1038/onc.2017.240 · Cited by 73
Therapeutic microRNAs in human cancer
Kumoğlu, G. Ö., İz, S. G., & Avcı, Ç. B. (2019) · Cytotechnology · doi:10.1007/s10616-018-0291-8 · Cited by 69
Wang, L.-Q., Yu, P., Li, B., Guo, Y.-H., Liang, Z., Zheng, L., Yang, J.-H., Xu, H., Liu, S., Zheng, L.-S., et al. (2018) · Molecular Oncology · doi:10.1002/1878-0261.12376 · Cited by 68
Chen, B., Zhang, D., Kuai, J., Cheng, M.-K., Fang, X., & Li, G. (2017) · Tumor Biology · doi:10.1177/1010428317715155 · Cited by 66
Zuo, J., Yu, Y., Zhu, M., Jing, W., Yu, M., Chai, H., Liang, C., & Tu, J. (2017) · Cancer Biomarkers · doi:10.3233/cbm-170642 · Cited by 66
Shi, L., Xi, J., Xu, X., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.080 · Cited by 66
MiR-27a Modulates Radiosensitivity of Triple-Negative Breast Cancer (TNBC) Cells by Targeting CDC27
Han, J. (2015) · Medical Science Monitor · doi:10.12659/msm.893974 · Cited by 63
Han, Z., Zhou, X., Li, S., Qin, Y., Chen, Y., & Liu, H. (2017) · Oncology Reports · doi:10.3892/or.2017.5938 · Cited by 63
miR-1301-3p promotes prostate cancer stem cell expansion by targeting SFRP1 and GSK3β
Song, X., Huang, B., Zhou, B., Wang, C., Liao, Z.-W., Yu, Y., & Zhao, S. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.01.086 · Cited by 63
Chang, Y., Jan, C., Peng, C., Lai, Y.-C., Hu, F., & Yu, C. (2015) · Oncotarget · doi:10.18632/oncotarget.4365 · Cited by 62
Xie, Q. M., Wang, S., Zhao, Y., Zhang, Z., Qin, C., & Yang, X. (2017) · Oncotarget · doi:10.18632/oncotarget.15781 · Cited by 62
Mei, Y., Gao, C., Wang, K., Cui, L., Li, W., Zhao, X., Liu, F., Wu, M., Deng, G., Ding, W., et al. (2014) · Cancer Science · doi:10.1111/cas.12370 · Cited by 60
Shi, D.-M., Bian, X., Qin, C., & Wu, W. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s152611 · Cited by 60
Gastric Cancer Stem Cells: Mechanisms and Therapeutic Approaches
Fu, Y., Du, P., Zhao, J., Hu, C., Qin, Y., & Huang, G. (2018) · Yonsei Medical Journal · doi:10.3349/ymj.2018.59.10.1150 · Cited by 60
Xie, Y., Du, J., Liu, Z., Zhang, D., Yao, X., & Yang, Y. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-1020-z · Cited by 60
Roles of microRNA-140 in stem cell-associated early stage breast cancer
Wolfson, B., Eades, G., & Zhou, Q. (2014) · World Journal of Stem Cells · doi:10.4252/wjsc.v6.i5.591 · Cited by 59
Jiang, J., Feng, X., Zhou, W., Wu, Y., & Yang, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.12283 · Cited by 58
MicroRNA-383 located in frequently deleted chromosomal locus 8p22 regulates CD44 in prostate cancer
Bucay, N., Sekhon, K., Yang, T. L., Majid, S., Shahryari, V., Hsieh, C.-L., Mitsui, Y., Deng, G., Tabatabai, Z. L., Yamamura, S., et al. (2016) · Oncogene · doi:10.1038/onc.2016.419 · Cited by 57
Osaki, M., Okada, F., & Ochiya, T. (2015) · Therapeutic Delivery · doi:10.4155/tde.14.122 · Cited by 56
Lin, X., Chen, W., Wei, F., Zhou, B. P., Hung, M., & Xie, X. (2017) · Theranostics · doi:10.7150/thno.20771 · Cited by 56
Han, T.-S., Voon, D. C., Oshima, H., Nakayama, M., Echizen, K., Sakai, E., Yong, Z. W. E., Murakami, K., Yu, L., Minamoto, T., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.11.059 · Cited by 55
Haghpanah, V., Fallah, P., Tavakoli, R., Naderi, M., Samimi, H., Soleimani, M., & Larijani, B. A. (2015) · Tumor Biology · doi:10.1007/s13277-015-3923-z · Cited by 54
Chen, F., Luo, N., Hu, Y., Li, X., & Zhang, K. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000491526 · Cited by 54
Current understanding and clinical utility of miRNAs regulation of colon cancer stem cells
Robertis, M. D., Poeta, M. L., Signori, E., & Fazio, V. M. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.08.008 · Cited by 54
Bonetti, P., Climent, M., Panebianco, F., Tordonato, C., Santoro, A., Marzi, M. J., Pelicci, P. G., Ventura, A., & Nicassio, F. (2018) · Oncogene · doi:10.1038/s41388-018-0445-3 · Cited by 54
Wu, G., Liu, A., Zhu, J., Lei, F., Wu, S., Zhang, X., Ye, L., Cao, L., & He, S. (2015) · Oncotarget · doi:10.18632/oncotarget.4921 · Cited by 53
Jiang, C., Yu, M., Xie, X., Huang, G., Peng, Y., Ren, D., Lin, M., Liu, B., Liu, M., Wang, W., et al. (2017) · Oncology Reports · doi:10.3892/or.2017.5924 · Cited by 53
Liu, R., Liu, C., Zhang, D., Liu, B., Chen, X., Rycaj, K., Jeter, C. R., Calhoun‐Davis, T., Li, Y., Yang, T., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10652 · Cited by 52
Li, X., He, J., Shao, M., Cui, B., Peng, F., Li, J., Ran, Y., Jin, D., Kong, J., Chang, J., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.06.151 · Cited by 52
Lu, A.-Q., Lv, B., Qiu, F., Wang, X., & Cao, X. (2017) · Oncology Reports · doi:10.3892/or.2017.5498 · Cited by 50
Robertis, M. D., Mazza, T., Fusilli, C., Loiacono, L., Poeta, M. L., Sanchez, M., Massi, E., Lamorte, G., Diodoro, M. G., Pescarmona, E. O., et al. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0912-z · Cited by 50
Prokopi, M., Kousparou, C. A., & Epenetos, A. A. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2014.00389 · Cited by 49
López‐Lázaro, M. (2015) · Oncoscience · doi:10.18632/oncoscience.159 · Cited by 49
Moriya, C., Taniguchi, H., Miyata, K., Nishiyama, N., Kataoka, K., & Imai, K. (2017) · Carcinogenesis · doi:10.1093/carcin/bgx040 · Cited by 48
microRNAs in cancer stem cells: current status and future directions
Chhabra, R., & Saini, N. (2014) · Tumor Biology · doi:10.1007/s13277-014-2264-7 · Cited by 47
Yang, L., Liu, D., Dong, L., Wen, D., Shi, D.-M., Zhou, J., Fan, J., & Wu, W. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.282 · Cited by 47
Ngalame, N. N. O., Makia, N. L., Waalkes, M. P., & Tokar, E. J. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.12.013 · Cited by 46
Cheng, C., Yu, J., Hsieh, Y., Liao, W., Shieh, J., Yao, C., Lee, H., Chen, P., Wu, P., & Shen, C. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000492561 · Cited by 46
Mamoori, A., Gopalan, V., Smith, R. A., & Lam, A. K.-Y. (2015) · Biology of the Cell · doi:10.1111/boc.201500062 · Cited by 44
Emerging role of microRNAs in cancer stem cells: Implications in cancer therapy
Garg, M. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i8.1078 · Cited by 43
The Role of microRNA in Head and Neck Cancer: Current Knowledge and Perspectives
Courthod, G., Franco, P., Palermo, L., Pisconti, S., & Numico, G. (2014) · Molecules · doi:10.3390/molecules19055704 · Cited by 42
Zhang, R., Xu, J., Zhao, J. H., & Bai, J. (2017) · Oncotarget · doi:10.18632/oncotarget.16779 · Cited by 42
Emerging Role of MicroRNAs in Cancer and Cancer Stem Cells
Hao, J., Zhao, S., Zhang, Y., Zhao, Z., Ye, R., Wen, J., & Li, J. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24702 · Cited by 41
Chen, C., Yang, Q., Wang, D., Luo, F., Liu, X., Xue, J., Yang, P., Xu, H., Lü, J., Zhang, A., et al. (2017) · Toxicology in Vitro · doi:10.1016/j.tiv.2017.12.016 · Cited by 41
Targeting liver cancer stem cells for the treatment of hepatocellular carcinoma
Li, N., & Zhu, Y. (2019) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284818821560 · Cited by 38
Lee, D., Sun, S., Zhang, X. Q., Zhang, P. D., Ho, A. S.-W., Kiang, K. M. Y., Fung, C. F., Lui, W., & Leung, G. (2015) · Journal of Cancer · doi:10.7150/jca.10765 · Cited by 37
Peng, C., Wang, T., Lee, S., Hsieh, P., Liao, Y., Tsai, L., Fang, C., Yu, C., & Hsieh, C. (2018) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12711 · Cited by 37
Yan, X., Liu, X., Wang, Z., Qian, C., Ji, G., Yang, H., Wan, L., Chen, G., Zeng, Q., Huang, H., et al. (2018) · Oncology Reports · doi:10.3892/or.2018.6930 · Cited by 37
Huang, C., Lin, C., Huang, Y., Wei, L., Ting, L., Kuo, C., Hsu, C.-Y., Chiou, J., Wu, A. T. H., & Lee, W. (2015) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.1446 · Cited by 36
Shao, Q., Xu, J., Guan, X., Zhou, B. R., Wei, W., Deng, R., Dong-zhen, L., Xu, X., & Zhu, H. (2017) · International Journal of Medical Sciences · doi:10.7150/ijms.21164 · Cited by 34
Sun, X., Xu, C., Xiao, G., Meng, J., Wang, J., Tang, S., Qin, S., Du, N., Li, G., Ren, H., et al. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3388 · Cited by 33
Liu, T., Qin, W., Hou, L., & Huang, Y. (2014) · Tumor Biology · doi:10.1007/s13277-014-2790-3 · Cited by 32
Molecular mechanisms of ovarian carcinoma metastasis: Key genes and regulatory microRNAs
Александровна, Б. Э., Fridman, M. V., & Кушлинский, Н. Е. (2017) · Biochemistry (Moscow) · doi:10.1134/s0006297917050017 · Cited by 32
Fang, C.-Y., Chen, P., Ho, D. C., et al. (2018) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2018.05.018 · Cited by 29
The Role of miRNAs in the Regulation of Pancreatic Cancer Stem Cells
Bimonte, S., Barbieri, A., Leongito, M., Palma, G., Vecchio, V. D., Falco, M., Palaia, R., Albino, V., Piccirillo, M., Amore, A., et al. (2016) · Stem Cells International · doi:10.1155/2016/8352684 · Cited by 27
Chen, C., Luo, F., Yang, Q., Wang, D., Yang, P., Xue, J., Dai, X., Liu, X., Xu, H., Lü, J., et al. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22772 · Cited by 27
MicroRNAs and breast cancer stem cells: Potential role in breast cancer therapy
Vahidian, F., Mohammadi, H., Ali‐Hassanzadeh, M., Derakhshani, A., Mostaan, M., Hemmatzadeh, M., & Baradaran, B. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27246 · Cited by 26
miR-26a/HOXC9 Dysregulation Promotes Metastasis and Stem Cell-Like Phenotype of Gastric Cancer
Peng, X., Kang, Q., Wan, R., & Wang, Z. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000493502 · Cited by 25
miR205 inhibits stem cell renewal in SUM159PT breast cancer cells
Mayoral-Varo, V., Calcabrini, A., Sánchez-Bailón, M. P., & Martı́n-Pérez, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188637 · Cited by 23
Mahabadi, J. A., Sabzalipoor, H., Nikzad, H., Seyedhosseini, E., Enderami, S. E., Hayat, S. M. G., & Sahebkar, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27990 · Cited by 23
Regulatory mechanisms of microRNAs in lung cancer stem cells
Fan, T. T., Wang, W., Zhang, B., Xu, Y., Chen, L., Pan, S., Hu, H., & Geng, Q. (2016) · SpringerPlus · doi:10.1186/s40064-016-3425-5 · Cited by 19
Implications of miRNAs in Colorectal Cancer Chemoresistance.
Ju, J. (2011) · PubMed · Cited by 18
Xu, P., Wang, J., Sun, B., & Xiao, Z. (2018) · Gene · doi:10.1016/j.gene.2018.02.065 · Cited by 13
Cited by
Exosomes: key players in cancer and potential therapeutic strategy
Dai, J., Su, Y., Zhong, S., Cong, L., Liu, B., Yang, J., Tao, Y., He, Z., Chen, C., & Jiang, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00261-0 · Cited by 1,186
Nedeljković, M., & Damjanović, A. (2019) · Cells · doi:10.3390/cells8090957 · Cited by 870
Loh, J.-J., & Ma, S. (2024) · Cell Stem Cell · doi:10.1016/j.stem.2024.04.004 · Cited by 314
Rah, B., Rather, R. A., Bhat, G. R., Baba, A. B., Mushtaq, I., Farooq, M., Yousuf, T., Dar, S. B., Parveen, S., Hassan, R., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.821344 · Cited by 202
Metadata
- Authors
- Khan, A., Ahmed, E., Elareer, N., Junejo, K., Steinhoff, M., & Uddin, S.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2019-08-05
- Volume
- 8
- Issue
- 8
- Pages
- 840
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W2965470749
- Cited by
- 297
- References
- 179
- FWCI
- 11.27
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.